12/03/2025 - Enanta Pharmaceuticals Inc.: Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium

[X]

The text version of this document is not available. You can access the original document here.

Disclaimer

Enanta Pharmaceuticals Inc. published this content on March 12, 2025, and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 12, 2025 at 12:52:36.642.

MoneyController also suggests